Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?

1Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Plain Language Summary: Patients with colorectal cancer that has spread to the lining of the abdomen (peritoneum) benefit from surgery to remove all the cancer. The addition of certain types of intra-abdominal chemotherapy during surgery improves survival for select patients.

References Powered by Scopus

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

2717Citations
N/AReaders
Get full text

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer

1778Citations
N/AReaders
Get full text

Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis from Colorectal Cancer: A Multi-Institutional Study

1048Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Witmer, H. D. D., Dhiman, A., & Turaga, K. K. (2023). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand? Cancer, 129(4), 495–502. https://doi.org/10.1002/cncr.34567

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

86%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Save time finding and organizing research with Mendeley

Sign up for free